This
volume brings together leading authorities in the field
of pituitary disease to discuss basic and clinical
topics covering the mechanisms of pituitary disease,
peripheral hormone action and new therapies.
Chapters cover pituitary developmental abnormalities
and lessons learnt from growth hormone replacement in
adults. There is a valuable insight into the functional
interaction between peripheral hormones and the pituitary
gland in the control of the metabolic process. In addition,
comprehensive reviews on the role of androgens in women,
the therapeutic potential of somatostatin analogues and
glucocorticoid replacement are complemented by updates
on Kallmann’s syndrome, craniopharyngiomas and
the role of P27 in pituitary tumorigenesis.
Endocrine scientists and clinicians will find this
volume a thorough review of the approaches and the
mechanistic basis of pituitary disease. It represents
excellence in current literature.
Chapters
- Pituitary developmental abnormalities:
molecular basis of clinical phenotype
J Drouin, A-M Pulichino, and S Vallette-Kasic,
Institut de recherches clinique de Montréal,
Canada
- Kallmann syndrome and FGF-insufficiency
C Dodé, Institut Cochin et Laboratoire de
Biochimie et Génétique Moléculaire
and J-P Hardeli, Institut Pasteur, Paris, France
- p27Kip1 and G1 cell cycle machinery in pituitary
tumorigenesis
H Kiyokawa, Northwestern University, Chicago,
USA
- Craniopharyngiomas: a clinicopathologic spectrum
B W Scheithauer, Mayo Support Center South 1, USA
- 11?-Hydroxysteroid dehydrogenase type 1 and obesity
J R Seckl and B R Walker, Western General Hospital,
Edinburgh UK
- The role of peptide YY in the regulation of
appetite and energy homeostasis
D Boey and H Herzog, Garvan Institute of Medical
Research, Sydney, Australia
- The metabolic syndrome as a modern maladaption
syndrome
T Funahashi, Osaka University Graduate School
of Medicine, and Y Matsuzawa, Sumitomo Hospital,
Osaka, Japan
- Aromatase and metabolic regulation
E R Simpson, M E Jones, and C D Clyn, Prince Henry's
Institute of Medical Research, Monash Medical Centre,
Clayton, Australia
Androgens in women – new treatments and
perspectives
W Arlt, University of Birmingham, Institute of
Biomedical Research, UK
- Selective somatostatin analogs in treating pituitary
tumors
A Ben-Shlomo, K A Wawrowsky, and S Melmed,
Cedars Sinai Research Institute, USA
- Glucocorticoid
replacement: new facets to an old problem
R J M Ross, University of Sheffield, Clinical
Sciences Centre, UK
- Growth hormone replacement in adults – lessons
learnt and future perspectives
A Jostel, R D Murray, and S M Shalet, Christie
Hospital, Manchester, UK
- Presentation of the 2005 Winner of the Eli Lilly
HypoCCS Award: Professor Anthony P Heaney P
C Sizonenko, Geneva, Switzerland
- Targeting pituitary tumors
A P Heaney, Cedars-Sinai Research Medical Center,
Los Angeles, USA
Subject areas: Endocrinology, Pituitary
Key words: Pituitary, growth and development, hormone
interventions
Market: Clinicians, clinical researchers, lecturers
and registrars in rheumatology or general medicine.
|
BioScientifica
Books 
